斯奇康佐治结核性胸膜炎疗效分析

Curative Effect Analysis of BCG-PSN for Assisting to Treat Tuberculosis Pleuritis

目的 观察斯奇康注射液的免疫治疗效果 ,缩短结核性胸膜炎胸水吸收时间及减少胸膜增厚后遗症。方法 随机抽样分为斯奇康治疗组和对照组 ,在全身化疗的基础上 ,斯奇康注射液胸膜腔注入。结果 近期疗效有差异 ,胸水吸收治愈率 ,治疗组为 84 .3% ,对照组为 5 0 .0 % ;胸水 10d以内吸收者 ,治疗组与对照组分别为 4 3.7%和 12 .5 % ;胸膜增厚 ,治疗组 15 .6 % ,对照组为 5 0 .0 %。

Objective to observe immunological curative effect of BCG-PSN (polysaccharide nucleic acid fraction of Bacillus Calmette Guerin) injecta, shorten hydrothorax absorption time of tuberculosis pleuritis and reduce pachynsis.Methods Cases were divided into treatment group with BCG-PSN and control group. Pleural cavities of Cases in treatment group were given BCG-PSN on basis of chemical treatment.Results There were significant differences of curative effect between the two groups. Hydrothorax absorption cure rate of treatment group was 84.3% and that of control group was 50.0%. 43.7% cases hydrothorax in treatment group was absorbed completely within 10 days and 12.5% cases hydrothorax in control group was absorbed completely in the same period. Pachynsis of treatment group was 15.6% and that of control group was 50.0%.Conclusions BCG-PSN was of higher application value to treat tuberculosis pleuritis by injecting BCG-PSN into the patient's pleural cavity.